SG65705A1 - 3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals - Google Patents

3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals

Info

Publication number
SG65705A1
SG65705A1 SG1997004280A SG1997004280A SG65705A1 SG 65705 A1 SG65705 A1 SG 65705A1 SG 1997004280 A SG1997004280 A SG 1997004280A SG 1997004280 A SG1997004280 A SG 1997004280A SG 65705 A1 SG65705 A1 SG 65705A1
Authority
SG
Singapore
Prior art keywords
carboxamidoesters
hydroxypiridine
perparation
pharmaceuticals
Prior art date
Application number
SG1997004280A
Other languages
English (en)
Inventor
Klaus Weidmann
Karl-Heinz Baringhaus
Georg Tschank
Martin Bickel
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of SG65705A1 publication Critical patent/SG65705A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
SG1997004280A 1996-12-04 1997-12-03 3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals SG65705A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19650215A DE19650215A1 (de) 1996-12-04 1996-12-04 3-Hydroxypyridin-2-carbonsäureamidester, ihre Herstellung und ihre Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
SG65705A1 true SG65705A1 (en) 1999-06-22

Family

ID=7813570

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1997004280A SG65705A1 (en) 1996-12-04 1997-12-03 3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals

Country Status (18)

Country Link
US (1) US6020350A (no)
EP (1) EP0846685B1 (no)
JP (1) JPH10168062A (no)
KR (1) KR19980063725A (no)
CN (1) CN1184104A (no)
AR (1) AR010328A1 (no)
AT (1) ATE214371T1 (no)
AU (1) AU743750B2 (no)
BR (1) BR9706129A (no)
CA (1) CA2223366A1 (no)
CZ (1) CZ383297A3 (no)
DE (2) DE19650215A1 (no)
HU (1) HUP9702345A2 (no)
NO (1) NO309717B1 (no)
NZ (1) NZ329299A (no)
PL (1) PL323517A1 (no)
SG (1) SG65705A1 (no)
TR (1) TR199701490A2 (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306839B1 (en) 1998-09-16 2001-10-23 Dow Agrosciences Llc 2-methoxyimino-2-(pyridinyloxymethyl) phenyl acetamides with (derivatised) hydroxyalkyl derivatives on the pyridine ring
AU780698B2 (en) 1999-07-20 2005-04-14 Dow Agrosciences Llc Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
US8318703B2 (en) 2001-12-06 2012-11-27 Fibrogen, Inc. Methods for improving kidney function
ES2686626T3 (es) * 2001-12-06 2018-10-18 Fibrogen, Inc. Medicamentos para tratar anemia asociada con enfermedad renal
EP2295060B1 (en) 2001-12-06 2018-10-31 Fibrogen, Inc. Treatment or prevention of ischemic or hypoxic conditions
US7618940B2 (en) * 2002-12-06 2009-11-17 Fibrogen, Inc. Fat regulation
US8124582B2 (en) 2002-12-06 2012-02-28 Fibrogen, Inc. Treatment of diabetes
US8614204B2 (en) * 2003-06-06 2013-12-24 Fibrogen, Inc. Enhanced erythropoiesis and iron metabolism
JP5410751B2 (ja) 2005-06-15 2014-02-05 ファイブローゲン、インコーポレーテッド がん治療のための化合物および方法
WO2007101204A1 (en) * 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
US7745461B1 (en) 2006-02-27 2010-06-29 Alcon Research, Ltd. Method of treating dry eye disorders
US7588924B2 (en) 2006-03-07 2009-09-15 Procter & Gamble Company Crystal of hypoxia inducible factor 1 alpha prolyl hydroxylase
KR100934671B1 (ko) * 2006-03-30 2009-12-31 엘지전자 주식회사 비디오 신호를 디코딩/인코딩하기 위한 방법 및 장치
ES2354584T3 (es) * 2006-06-26 2011-03-16 Warner Chilcott Company, Llc Inhibidores de prolilhidroxilasa y métodos de uso.
US8962530B2 (en) * 2007-06-27 2015-02-24 Regents Of The University Of Colorado Inflammatory bowel disease therapies
RU2518416C2 (ru) 2009-11-06 2014-06-10 Аэрпио Терапьютикс Инк. Композиции и способы лечения колита
EP3251671A1 (en) 2011-06-06 2017-12-06 Akebia Therapeutics Inc. Compositions for stabilizing hypoxia inducible factor-2 alpha as a method for treating cancer
NO2686520T3 (no) 2011-06-06 2018-03-17
NZ753904A (en) 2013-06-13 2020-07-31 Akebia Therapeutics Inc Compositions and methods for treating anemia
TW201946625A (zh) 2013-11-15 2019-12-16 美商阿克比治療有限公司 {[5-(3-氯苯基)-3-羥基吡啶-2-羰基]胺基}乙酸之固體型式,其組合物及用途
AU2015209264A1 (en) * 2014-01-23 2016-08-04 Akebia Therapeutics, Inc. Compositions and methods for treating ocular diseases
EP3247355A4 (en) 2015-01-23 2018-06-13 Akebia Therapeutics, Inc. Solid forms of 2-(5-(3-fluorophenyl)-3-hydroxypicolinamido)acetic acid, compositions, and uses thereof
CN106146395B (zh) * 2015-03-27 2019-01-01 沈阳三生制药有限责任公司 3-羟基吡啶化合物、其制备方法及其制药用途
MA41863A (fr) 2015-04-01 2021-06-02 Akebia Therapeutics Inc Compositions et procédés permettant de traiter une anémie
JP6814134B2 (ja) * 2015-05-28 2021-01-13 日本たばこ産業株式会社 糖尿病性腎症を治療又は予防する方法
CA3097219A1 (en) 2018-05-09 2019-11-14 Akebia Therapeutics, Inc. Process for preparing 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
US11524939B2 (en) 2019-11-13 2022-12-13 Akebia Therapeutics, Inc. Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino} acetic acid
IT201900021960A1 (it) * 2019-11-22 2021-05-22 Isagro Spa Composti ad attività fungicida, loro composizioni agronomiche e relativo metodo di preparazione
CN112979541B (zh) * 2019-12-17 2022-11-11 浙江大学 一种基于n-(3-羟基吡啶-2-羰基)甘氨酸的抗肿瘤药物增敏剂及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4015255A1 (de) * 1990-05-12 1991-11-14 Hoechst Ag Oxalyl-aminosaeurederivate, verfahren zu ihrer herstellung und ihrer verwendung als arzneimittel zur inhibierung der prolyl-hydroxylase
TW406076B (en) * 1993-12-30 2000-09-21 Hoechst Ag Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
IL135495A (en) * 1995-09-28 2002-12-01 Hoechst Ag Intermediate compounds for the preparation of quinoline-converted amines - 2 - carboxylic acid

Also Published As

Publication number Publication date
DE59706602D1 (de) 2002-04-18
TR199701490A2 (xx) 1998-06-22
HUP9702345A2 (hu) 2002-11-28
JPH10168062A (ja) 1998-06-23
CN1184104A (zh) 1998-06-10
KR19980063725A (ko) 1998-10-07
EP0846685B1 (de) 2002-03-13
NO309717B1 (no) 2001-03-19
CZ383297A3 (cs) 1998-06-17
MX9709438A (es) 1998-06-30
AR010328A1 (es) 2000-06-07
AU743750B2 (en) 2002-02-07
CA2223366A1 (en) 1998-06-04
NO975513L (no) 1998-06-05
EP0846685A1 (de) 1998-06-10
PL323517A1 (en) 1998-06-08
DE19650215A1 (de) 1998-06-10
NO975513D0 (no) 1997-12-01
NZ329299A (en) 1998-11-25
AU4679297A (en) 1998-06-11
ATE214371T1 (de) 2002-03-15
BR9706129A (pt) 1999-05-18
HU9702345D0 (en) 1998-03-02
US6020350A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
SG65705A1 (en) 3-Hydroxypiridine-2-carboxamidoesters their perparation and their use as pharmaceuticals
GB9620390D0 (en) Substances and their uses
ZA9711141B (en) Novel ketobenzamides and their use
ZA989505B (en) Substituted isoquinoline-3-carboxamides their preparation and their use as pharmaceuticals
HUP0000369A3 (en) 3-thiocarbamoylpyrazole derivatives and their use as pesticides
EP1021185A4 (en) DIHYDROPYRIMIDINE AND ITS USES.
IL120124A0 (en) Heteroaryl-oxazolidinones their preparation and use
PL320565A1 (en) Substances and their application
GB9625899D0 (en) Substances and their uses
HUP9700446A3 (en) Oilsuspension-concentrate and using thereof
IL116001A0 (en) Alkoxyimino-acetimidates and their use as pesticides
PL331523A1 (en) Azolotrizines and azolopyrimidines
EP0744125A3 (en) Iodine complex and its application
IL123535A0 (en) Benzoxazindione derivatives and their use
IL116014A0 (en) Iminooxymethyleneanilides their preparation and their use
PL328334A1 (en) Preparation and application thereof
HUT76130A (en) Amino-acid-derivatives and their use as pesticide
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
GB9616504D0 (en) Therapeutic product and its use
IL115853A0 (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas
GB9424939D0 (en) Substances and their uses
GB9424938D0 (en) Substances and their uses
GB9425033D0 (en) Substances and their uses
GB9424835D0 (en) Substances and their uses
GB9424900D0 (en) Substances and their uses